, Volume 127, Issue 1–2, pp 88–94 | Cite as

Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy

  • S. M. Babb
  • K. E. Appelmans
  • P. F. Renshaw
  • R. J. Wurtman
  • B. M. Cohen
Original Investigation


Phosphatidylcholine (PtdCho), which is essential for membrane integrity and repair, is reduced in brain cell membranes with age. Evidence from both animal and in vitro studies indicates that cytidine 5′ diphosphate choline (CDP-choline) can increase the synthesis of PtdCho; however, the effect of CDP-choline on brain choline metabolism has not previously been studied in human subjects. In this study, in vivo proton magnetic resonance spectroscopy (1H-MRS) was used to measure brain levels of cytosolic, cholinecontaining compounds before and after single oral doses of CDP-choline. Three hours after dosing, plasma choline increased similarly in younger (mean age 25 years) and older subjects (mean age 59 years). However, while the choline resonance in brain increased by 18% on average in younger subjects, it decreased by almost 6% in older subjects (P=0.028). These results may be explained by a previously observed decrease in brain choline uptake, but not cytidine uptake, in older subjects. Additional intracellular cytidine following the administration of CDP-choline should lead to the increased incorporation of choline already present in brain into membrane PtdCho, which is not MRS-visible, consequently lowering the brain choline resonance below that of pre-treatment values. These results suggest that the cytidine moiety of CDP-choline stimulates phosphatidylcholine synthesis in human brain cell membranes in older subjects.

Key words

5′-Cytidine diphosphate choline Choline Phosphatidylcholine Cytidine Aging Brain Magnetic resonance spectroscopy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agut J, Lopez G-Coviella I, Ortiz JA, Wurtman RJ (1993) Oral cytidine 5′-diphosphate choline administration to rats increases brain phospholipid levels. Ann NY Acad Sci 695:318–320PubMedCrossRefGoogle Scholar
  2. Bartus RT (1990) Drugs to treat age-related neurodegenerative problems. J Am Geriatric Soc 38:680–695Google Scholar
  3. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–410PubMedCrossRefGoogle Scholar
  4. Bligh J (1953) The role of the liver and the kidneys in the maintenance of the level of free choline in plasma. J Physiol (London) 120:53–62Google Scholar
  5. Cohen BM, Zubenko GS (1985) Aging and the biophysical properties of cell membranes. Life Sci 37:1403–1409PubMedCrossRefGoogle Scholar
  6. Cohen BM, Stoll A, Renshaw P, DeMicheli E, Wurtman RJ (1994) Differences in choline uptake in brain measured in vivo by proton MRS in young and elderly adults. Soc Magn Reson Abstr 1:311Google Scholar
  7. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM (1995) Decreased brain choline uptake in older adults: an in vivo proton magnetic resonance spectroscopy study. JAMA 274:902–907PubMedCrossRefGoogle Scholar
  8. Cornford EM, Oldendorf WH (1975) Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim Biophys Acta 394:211–219PubMedCrossRefGoogle Scholar
  9. Cornford EM, Braun LD, Oldendorf WH (1978) Carrier mediated blood-brain barrier transport of choline and certain choline analogs. J Neurochem 30:299–308PubMedCrossRefGoogle Scholar
  10. De Rosa M, Galletti P, Romeo G, Nappi A, Pontoni G, Arrigoni E, Zappia V (1985) Pharmacokinetics and metabolism of double-labeled CDP choline. In: Zappia V, Kennedy EP, Nilsson BI, Galletti P (eds) Novel biochemical, pharmacological and clinical aspects of cytidinediphosphocholine. Elsevier, New York, pp 139–157Google Scholar
  11. Eckernäs SA, Aquilonius SM (1977) Free choline in human plasma analysed by simple radio-enzymatic procedure: age distribution and effect of a meal. Scand J Clin Lab Invest 37:183–187PubMedGoogle Scholar
  12. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R (1989) Localized proton NMR spectroscopy in different regions of human brain in vivo. Relaxation times and concentrations of cerebral metabolites Magn Reson Med 11:47–63PubMedCrossRefGoogle Scholar
  13. Gallai V, Mazzotta G, Firenze S, Montesi S, Del Gatto F (1991) Study of the P300 and cerebral maps in subjects with multi-infarct dementia treated with cytidine. Psychopharmacology 103:1–5PubMedCrossRefGoogle Scholar
  14. Galletti P, DeRosa M, Cotticelli MG, Morana A, Vaccaro R, Zappia V (1991) Biochemical rationale for the use of CDP-choline in traumatic brain injury: pharmacokinetics of the orally administered drug. J Neurol Sci 103:S19-S25PubMedCrossRefGoogle Scholar
  15. Grinni LS (1977) Changes in cell membranes during aging. Gerontology 23:452–464Google Scholar
  16. Hartford JT, Hsu L, Samorajski T, Ordy JM (1984) Changes in blood choline and cholinergic enzymes during aging in man. In: Ordy JM, Harman D, Alfin-Slater RB (eds) Aging, vol. 26: nutrition in gerontology. Raven Press, New York, pp 227–241Google Scholar
  17. Hicks P, Rolsten D, Taylor D, Samorajski T (1982) Plasma choline and blood cholinesterases in aged rats. Gerontology 28: 104–107PubMedCrossRefGoogle Scholar
  18. Jellinger K, Kienzl E, Puchinger L, Stachelberger H (1993) Changes of phospholipids in Alzheimer’s disease brain. In: Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P (eds) Alzheimer’s disease: advances in clinical and basic research. Wiley, New York pp 315–323Google Scholar
  19. Kalaria RN, Harik SI (1986) Nucleoside transporter of cerebral microvessels and choroid plexus. J Neurochem 47:1849–1856PubMedCrossRefGoogle Scholar
  20. Kang YS, Terasaki T, Ohnishi T, Tsuji A (1990) In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier. J Pharmacobio-Dyn 113:353–360Google Scholar
  21. Kennedy EP, Weiss SP (1956) The function of cytidine coenzymes in the biosynthesis of phospholipids. J Biol Chem 222:193–214PubMedGoogle Scholar
  22. Klein J, Köppen A, Löffelholz K (1991) Uptake and storage of choline by rat brain: Influence of dietary choline supplementation. J Neurochem 57:370–375PubMedCrossRefGoogle Scholar
  23. Klein J, Köppen A, Löffelholz K, Schmitthenner J (1992) Uptake and metabolism of choline by rat brain, after acute choline administration. J Neurochem 58:870–876PubMedCrossRefGoogle Scholar
  24. Klein J, Gonzalez R, Köppen A, Löffelholz K (1993) Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 22:293–300PubMedCrossRefGoogle Scholar
  25. Löffelholz K, Klein J, Köppen A (1993) Choline a precursor of acetylcholine and phospholipids in the brain. Prog Brain Res 98:197–200PubMedGoogle Scholar
  26. Lopez G-Coviella I, Agut J, Wurtman RJ, Robinson, L, Ortiz JA (1988) Precursor control of phospholipid metabolism in aged mice and in neurally-derived cells in culture. Second International Serling Symposium on the Biology of Aging, Weizman Institute of Science, Rehovot, Israel, p 73Google Scholar
  27. Miller BL (1991) A review of chemical issues in1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline, NMR Biomed 4:47–52PubMedCrossRefGoogle Scholar
  28. Miller LG (1990) Dietary choline alteration: implications for γ-aminobutyric acid and other neurotransmitter receptors. Biochem Pharmacol 40:1179–1182PubMedCrossRefGoogle Scholar
  29. Millington WR, Wurtman RJ (1982) Choline administration elevates brain phosphorylcholine concentrations. J Neurochem 38: 1748–1752PubMedCrossRefGoogle Scholar
  30. Mooradian, AD (1988) Blood-brain barrier transport of choline is reduced in the aged rat. Brain Res 440:328–332PubMedCrossRefGoogle Scholar
  31. Pelech SL, Vance DE (1984) Regulation of phosphocholine biosynthesis. Biochim Biophys Acta 779:217–251PubMedGoogle Scholar
  32. Pepeu G, Giovannelli L (1994) The central cholinergic system during aging. In: Bloom F (ed) Progess in brain research, vol. 100. Elsevier, Amsterdam, pp 67–71Google Scholar
  33. Petroff OAC (1988) Biological1H NMR spectroscopy. Comp Biochem Physiol [B] 90:249–260CrossRefGoogle Scholar
  34. Petroff OAC, Ogino T, Alger JR (1988) High-resolution proton magnetic resonance spectroscopy of rabbit brain: Regional metabolite levels and postmortem changes. J Neurochem 51:163–171PubMedCrossRefGoogle Scholar
  35. Petroff OAC, Spencer DD, Alger JR, Prichard JW (1989) High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 39:1197–1202PubMedGoogle Scholar
  36. Plagemann PGW (1971) Nucleoside transport by Novikoff rat hepatoma cells growing in suspension culture. Biochim Biophys Acta 233:688–701PubMedCrossRefGoogle Scholar
  37. Roth GS, Joseph JA, Mason RP (1995) Membrane alterations as causes of impaired signal transduction in Alzheimer’s disease and aging. Trends Neurosci: 18:203–206PubMedCrossRefGoogle Scholar
  38. Rouser G, Yamamoto A (1968) Curvilinear regression course of human brain lipid composition changes with age. Lipids 3:284–287PubMedCrossRefGoogle Scholar
  39. Savci V, Wurtman RJ (1995) Effect of cytidine on, membrane phospholipid synthesis in rat striatal slices. J Neurochem 64: 378–384PubMedCrossRefGoogle Scholar
  40. Scremin OU, Jenden DJ (1993) Acetylcholine turnover and release: the influence of energy metabolism and systemic choline availability. Prog Brain Res 98:191–195PubMedGoogle Scholar
  41. Secades JJ, Frontera G (1995) CDP-choline: Pharmacological and clinical review. Meth Find Exp Clin Pharmacol 17 [B]: 1–54Google Scholar
  42. Stoll AL, Renshaw PF, DeMicheli E, Wurtman R, Pillay SS, Cohen BM (1995) Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 37:170–174PubMedCrossRefGoogle Scholar
  43. Tucek S (1984) Problems in the organization and control of acetylcholine synthesis in brain neurons. Prog Biophys Mol Biol 44:1–46PubMedCrossRefGoogle Scholar
  44. Ulus IH, Wurtman RJ, Mauron C, Blusztajn, JK (1989) Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res 484:217–227PubMedCrossRefGoogle Scholar
  45. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE (1994) Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 31: 365–373PubMedCrossRefGoogle Scholar
  46. Weiss GB (1995) Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci 56:637–660PubMedCrossRefGoogle Scholar
  47. Whitchead FW, Trip E, Vance DE (1981) Semliki Forest virus does not inhibit phosphatidylcholine biosynthesis in BHK-21 cells. Can J Biochem 59:38–47CrossRefGoogle Scholar
  48. Wurtman RJ (1992) Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci 15:117–122PubMedCrossRefGoogle Scholar
  49. Yashima K, Takamatsu M, Okuda K (1975). Intestinal absorption of cytidine diphosphate choline and its changes in the digestive tract. J Nutr Sci Vitaminol [Tokyo] 21:49–60Google Scholar
  50. Zeisel SH (1992) Choline: an important nutrient in brain development liver function and carcinogenesis. J Am Coll Nutr 11: 473–481PubMedGoogle Scholar
  51. Zeisel SH, daCosta KA (1990) Choline: determination using gas chromatography/mass spectrometry. J Nutr Biochem 1:55–59PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • S. M. Babb
    • 1
  • K. E. Appelmans
    • 1
  • P. F. Renshaw
    • 1
    • 2
  • R. J. Wurtman
    • 3
  • B. M. Cohen
    • 1
    • 2
  1. 1.Brain Imaging CenterMcLean HospitalBelmontUSA
  2. 2.Consolidated Department of PsychiatryHarvard Medical SchoolBostonUSA
  3. 3.Department of Brain and Cognitive SciencesMassachusetts Institute of TechnologyCambridgeUSA

Personalised recommendations